Data Collected From 582 Non-Small Cell Lung Cancer Patients Who Underwent Stereotactic Body Radiotherapy
A working group called Extracranial Stereotactic Radiotherapy was formed within the German Society for Radiation Oncology and this group performed a patterns-of-care and patterns-of-outcome analysis looking at safety and efficacy of SBRT for stage I NSCLC in Germany and Austria. Their research, published in the August issue of the Journal of Thoracic Oncology (JTO), concludes SBRT for stage I NSCLC was safe and effective in this multi-institutional environment. In addition, radiotherapy dosage was identified as a major treatment factor influencing local tumor control and overall survival.
The researchers looked at data from 582 patients treated at 13 institutions between 1998 and 2011. Average follow-up for all patients was 21.4 months and the maximum was 144 months (12 years); follow-up was more than 3 years for 108 patients. Three-year freedom from local progression was 79.6 percent for all 582 patients.
The biological effective dosage was the most significant factor influencing freedom from local progression and overall survival. No evidence of a learning curve or improvement of results with larger SBRT experience and implementation of new radiotherapy technologies was observed. The group concluded that SBRT for stage I NSCLC was safe and effective in this multi-institutional, academic environment, despite considerable inter-institutional variability and time trends in SBRT practice.
Source: EurekAlert!, the online, global news service operated by AAAS, the science society
Please use one of the following formats to cite this article in your essay, paper or report:
International Association for the Study of Lung Ca. "Data Collected From 582 Non-Small Cell Lung Cancer Patients Who Underwent Stereotactic Body Radiotherapy." Medical News Today. MediLexicon, Intl., 4 Jul. 2013. Web.
27 Jul. 2016. <http://www.medicalnewstoday.com/releases/262781.php>
International Association for the Study of Lung Ca. (2013, July 4). "Data Collected From 582 Non-Small Cell Lung Cancer Patients Who Underwent Stereotactic Body Radiotherapy." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.